$1.8 billion expansion groundbreaking today at Regeneron!!!
Governor Kathy Hochul today announced the groundbreaking for Regeneron's previously announced $1.8 billion research, preclinical manufacturing and support facilities at the company's Westchester County campus in Tarrytown. The company, a biotechnology leader that invents and manufactures life-transforming medicines for people with serious diseases, committed to creating at least 1,000 new full-time, high-skill jobs in the Mid-Hudson Region over the next five years. To encourage Regeneron's continued expansion in New York State, Empire State Development is supporting the project with up to $100 million in performance-based Excelsior Jobs Program tax credits, consistent with the company's hiring goals. Regeneron considered several potential sites in the tri-state area before deciding to expand in the Mid-Hudson region.
"New York is a leader in the life sciences industry in part due to the decades of investment and many groundbreaking scientific advancements at Regeneron," Governor Hochul said. "The COVID-19 crisis was one demonstration of how quickly and effectively Regeneron is able to deploy its drug discovery and development engine against devastating diseases. Regeneron's work has undoubtedly saved countless lives in New York and throughout the United States, and we are proud that Regeneron will continue to create good jobs and invest in the Mid-Hudson region as they work to make additional breakthroughs against blindness-causing diseases, cancer, genetic diseases and more.
No comments:
Post a Comment